drugset / Trial / NCT02335736
Antagonist Protocol in IVF
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The antagonist protocol in a novel method of stimulation in the in vitro fertilization (IVF) patients. It has been tried in poor responders, polycystic ovary (PCO) patients and normal females undergoing IVF. Can it be used with the same efficacy in all patients?
Timeline
- Start
- 2015-01
- Primary completion
- 2015-08
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetrorelix | Other / unclassified | 0.25 mg | Subcutaneous |